Sativex multiple sclerosis drug. Pharmacist holding a box containing Sativex. This cannabinoid oromucosal mouth spray was developed by GW Pharmaceutic


Sativex multiple sclerosis drug. Pharmacist holding a box containing Sativex. This cannabinoid oromucosal mouth spray was developed by GW Pharmaceuticals for multiple sclerosis patients. It is used to alleviate neuropathic pain, spasticity, overactive bladder, and other symptoms. It is also being trialled as a pain control drug for cancer patients.


Size: 5023px × 3543px
Photo credit: © MARK THOMAS/SCIENCE PHOTO LIBRARY / Alamy / Afripics
License: Licensed
Model Released: No

Keywords: adult, analgesic, asian, box, close-, detail, device, drug, gw, holding, human, male, man, medical, medicine, mouth, ms, multiple, nabiximols, oromucosal, packaging, pain, people, person, pharmaceuticals, pharmacological, pharmacology, pharmacy, prescribed, prescription, relief, sativex, sclerosis, shelf, spray, store, treatment